LBF20207PG36: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR1753 | |LipidBank=XPR1753 | ||
|LipidMaps=LMFA03010071 | |LipidMaps=LMFA03010071 | ||
|SysName=(9alpha,11alpha,15S) -Trihydroxy-prosta- (5- | |SysName=(9alpha,11alpha,15S) -Trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid, 1,11-lactone | ||
|Common Name=&&Prostaglandin | |Common Name=&&Prostaglandin F_2 alpha 1,11-lactone&&(9alpha,11alpha,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid, 1,11-lactone&& | ||
|Source= | |Source= |
Latest revision as of 08:34, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1753 |
LipidMaps | LMFA03010071 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG36 |
Prostaglandin F2α 1,11-lactone | |
---|---|
Structural Information | |
(9α,11α,15S) -Trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid, 1,11-lactone | |
| |
Formula | C20H32O4 |
Exact Mass | 336.23005951199997 |
Average Mass | 336.46567999999996 |
SMILES | C(CC[C@H](O)C=C[C@@H]([C@H]12)[C@H]([C@@H](O)C2)CC=CCCCC(=O)O1)CC |
Physicochemical Information | |
Prostaglandin F2 alpha 1,11-lactone shows reduction of vasoacitivity and anti-fertility effect. Bundy_GL et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|